Transforming growth factor-β (TGF-β) in the tumor microenvironment induces TAN populations with a pro-tumor phenotype (Fridlender et al. 2009), while interferon-β(IFN-β) can promote the N1 phenotype (Jablonska et al. 2010). The gene discussed is IFNB1; the disease is neoplasm.